报告主张将唐氏综合症患者纳入阿尔茨海默氏病临床试验, Report advocates including Down syndrome individuals in Alzheimer's clinical trials, suggesting treatments could improve their health outcomes by 40%.

Lumind IDSC基金会和其他方面的报告强调,投资于老年痴呆症患者的成人研究可以大大提高他们的生活质量,降低护理费用,并将寿命延长五年。 A report from the LuMind IDSC Foundation and others highlights that investing in Alzheimer's research for adults with Down syndrome could significantly enhance their quality of life, cut caregiving costs, and extend lifespans by five years. 报告指出,为普通民众提供的治疗可提高这一群体的健康和护理成果,最高可达40%。 It suggests that treatments developed for the general population could improve health and caregiving outcomes for this group by up to 40%. 报告主张将患有唐氏综合症的个人纳入临床试验,并强调早期老年痴呆症的检测。 The report advocates for including individuals with Down syndrome in clinical trials and emphasizes early Alzheimer's detection.